Evidence map›Paper›PMID 20810925›Full record

ArticleBlood2010

During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool.

Arvind Dev, Jing Fang, Pradeep Sathyanarayana, Anamika Pradeep, Christine Emerson, Don M Wojchowski

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Immunoregulation role of the erythroid cells.Frontiers in immunology · 2024
    Review
  2. Article
  3. CD71Frontiers in immunology · 2022
    Article
  4. Article
  5. Article
  6. Review
  7. Identification and Functional Analysis of EPORJournal of immunology research · 2020
    Article
  8. Article
  9. Visualization ofJournal of the American Society for Mass Spectrometry · 2017
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Arvind DevCOBRE Center of Excellence in Stem Cell Biology and Regenerative Medicine, Maine Medical Center Research Institute, Scarborough, ME, USA.
Jing Fang
Pradeep Sathyanarayana
Anamika Pradeep
Christine Emerson
Don M Wojchowski
Maine Medical Center · USMaine Medical Center Research Institute · US

Funding

WNT SIGNALING IN PREIMPLANTATION EMBRYOP20RR018789 · NCRR · MAINE MEDICAL CENTER · PI WANG, ZACK Z. · 2003 to 2011
$18.9M
IN VITRO STUDIES OF ERYTHROPOIETIN ACTIONR01HL044491 · NHLBI · UNIVERSITY OF NEW HAMPSHIRE · PI WOJCHOWSKI, DON MICHAEL · 1991 to 2020
$4.8M
Novel regulators of stress erythropoiesisR01DK089439 · NIDDK · UNIVERSITY OF NEW HAMPSHIRE · PI WOJCHOWSKI, DON MICHAEL · 2010 to 2017
$2.0M
NCRR NIH HHS P20 RR018789NCRR NIH HHS P20RR018789NHLBI NIH HHS R01 HL044491NHLBI NIH HHS R01 HL44491NIDDK NIH HHS R01 DK089439
6 · The paper itself

Abstract

Investigations of bone marrow (BM) erythroblast development are important for clinical concerns but are hindered by progenitor cell and tissue availability. We therefore sought to more specifically define dynamics, and key regulators, of the formation of developing BM erythroid cell cohorts. A unique Kit(-)CD71(high)Ter119(-) "stage E2" proerythroblast pool first is described, which (unlike its Kit(+) "stage E1" progenitors, or maturing Ter119(+) "stage E3" progeny) proved to selectively expand ∼ 7-fold on erythropoietin challenge. During short-term BM transplantation, stage E2 proerythroblasts additionally proved to be a predominantly expanded progenitor pool within spleen. This E1→E2→E3 erythroid series reproducibly formed ex vivo, enabling further characterizations. Expansion, in part, involved E1 cell hyperproliferation together with rapid E2 conversion plus E2 stage restricted BCL2 expression. Possible erythropoietin/erythropoietin receptor proerythroblast stage specific events were further investigated in mice expressing minimal erythropoietin receptor alleles. For a hypomorphic erythropoietin receptor-HM allele, major defects in erythroblast development occurred selectively at stage E2. In addition, stage E2 cells proved to interact productively with primary BM stromal cells in ways that enhanced both survival and late-stage development. Overall, findings reveal a novel transitional proerythroblast compartment that deploys unique expansion devices.

Indexed as

AnemiaCell ProliferationAllelesAnimalsBone Marrow TransplantationCell CommunicationErythroblastsErythroid Precursor CellsErythropoiesisErythropoietinMiceMice, Inbred C57BLReceptors, ErythropoietinSpleenStromal CellsErythropoietinReceptors, Erythropoietin

Identifiers

PMID20810925
PMCPMC3012546
OpenAlexW2014211485

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.